Latest News

Uterus Transplants in Women With Uterine-Factor Infertility Show High Rate of Live Births


 

TOPLINE:

Uterus transplants in women with absolute uterine-factor infertility resulted in a 70% success rate of women later giving birth.

METHODOLOGY:

  • The study included 20 women with uterine-factor infertility, a condition in which women do not have a uterus or have one that is not functional; each patient had at least one functioning ovary and uterine abnormalities.
  • All patients underwent womb transplantation at a large US specialized care center between 2016 and 2019.
  • The transplant was performed using grafts from 18 living donors and two deceased donors.
  • Patients received anti-rejection medication until the transplanted uterus was removed following one or two live births or graft failure.
  • Researchers measured uterus graft survival and subsequent live births.

TAKEAWAY:

  • Out of the 20 participants, 14 (70%) had successful uterus transplants and all 14 gave birth to at least one healthy infant.
  • Half of the successful pregnancies had complications, which included gestational hypertension (14%), cervical insufficiency (14%), and preterm labor (14%).
  • None of the 16 live-born infants had congenital malformations, and no developmental delays were observed as of May 2024.
  • Four of the 18 living donors experienced grade 3 complications, including ureteral obstruction and thermal injury to the ureters.

IN PRACTICE:

“Uterus transplant was technically feasible and was associated with a high live birth rate following successful graft survival,” wrote the authors of the study. “Adverse events were common, with medical and surgical risks affecting recipients as well as donors.”

SOURCE:

The study was led by Giuliano Testa, MD, MBA, of Baylor University Medical Center in Dallas, Texas, and was published online in JAMA Network.

LIMITATIONS:

The findings are based on data from a single center. The sample size was small. The high cost of uterus transplants limits generalizability.

DISCLOSURES:

No disclosures were reported.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication. A version of this article first appeared on Medscape.com.

Recommended Reading

Hemorrhage-control device holds up in real-world review
MDedge ObGyn
Less is more for axillary surgery in early breast cancer
MDedge ObGyn
Bariatric surgery tied to less pregnancy weight gain
MDedge ObGyn
Web-Based Aid Educates Women on Tubal Sterilization
MDedge ObGyn
Non-Radical Surgery a Win-Win for Early Cervical Cancer
MDedge ObGyn
Minimally Invasive Cytoreductive Approach Comparable to Open Surgery for Ovarian Cancer
MDedge ObGyn
Delaying Embryo Transfers May Benefit Patients With Endometrial Polyps
MDedge ObGyn
Myomectomy best for avoiding reintervention after fibroid procedures
MDedge ObGyn
Which Surgery for Vaginal Vault Prolapse? No Clear Winner
MDedge ObGyn
Could total mesometrial resection become a new standard treatment for cervical cancer?
MDedge ObGyn